FDA wants to know more
The Merck pharmaceutical company has revealed that Gefapixant, an experimental drug designed to overcome chronic cough, still has a way to go before the US market. As part of his…
The Merck pharmaceutical company has revealed that Gefapixant, an experimental drug designed to overcome chronic cough, still has a way to go before the US market. As part of his…